Neo-angiogenesis in Inguinal Henia Implant ProFlor

NCT04541316 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2020-09-10

No results posted yet for this study

Summary

The investigation is aimed at specifically demonstrating the ingrowth of newly formed vascular elements within ProFlor, a 3D dynamic responsive implant for inguinal hernia repair

Conditions

  • Inguinal Hernia

Interventions

DEVICE

ProFlor inguinal hernia device

Inguinal hernia repair

Sponsors & Collaborators

  • University of Cagliari

    lead OTHER

Principal Investigators

  • Giuseppe Amato · University of Cagliari

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2020-01-31
Completion
2020-07-31
FDA Device
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04541316 on ClinicalTrials.gov